A Safety and Efficacy Study of ELND002 in Patients With Relapsing Forms of Multiple Sclerosis
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and tolerability of ELND002 in patients
with relapsing forms of secondary progressive multiple sclerosis (SPMS) or
relapsing-remitting multiple sclerosis (RRMS).